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The understanding and management of Peyronie’s disease (PD) has improved but elucidating the exact etiology of the disease
has yet to be achieved. In this paper, we review the historical and clinical aspects of PD. We focus on the evolution of surgical
management for PD and review recent published articles that compare popular surgical techniques such as plication and plaque
incision with vein graft. These two techniques have been reported to be equivalent with respect to patient satisfaction; however,
each technique has its own advantages and disadvantages.
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1. INTRODUCTION
Peyronie’sdisease(PD)wasnamedaftertheFrenchphysician
Francois de la Peyronie in 1741. His original description was
oneoftheﬁbrouscavernositis“preventingthemfromhaving
normal ejaculation of semen” [1]. The disease is currently
thought to aﬀect between 3 and 9% of adult men, typically
in the ﬁfth to sixth decades of life. Overall, its prevalence
appears to be rising, though this may be due to the fact that
more men are seeking treatment for erectile dysfunction [2].
2. PATHOPHYSIOLOGY
Despite a volume of basic science and clinical research, much
remains unknown about the etiology and ideal management
of the disease. PD is a localized connective tissue disorder of
the penis leading to ﬁbrosis, scarring, and noncompliance
of the tunica albuginea. One etiologic theory is that the
root cause of the ﬁbrosis is ischemia and inﬂammation from
repeated penile trauma or microtrauma from activities such
as sexual intercourse. The resulting microvascular tears in
this region lead to collagen deposition in the form of plaques
[3].
Some studies have suggested a link between PD and
methotrexate, while others have shown a genetic predispo-
sition to the disease due to an association with Dupuytren’s
contracture and with HLA-B7 and HLA-B27 antigens. Still
other authors have identiﬁed circulating antibodies that may
point to a possible immunologic cause of PD [4–7].
3. CLINICAL PRESENTATION
Patients typically present with three, occasionally simultane-
ous, chief complaints: a palpable plaque, a painful erection,
and/or penile curvature. Penile curvature can in fact be so
severe in that it interferes with the ability to engage in sexual
intercourse (Figure 1). The disease undergoes a transition
between two phases: an acute inﬂammatory phase and a
chronicphase.Painfulerections,developingpenilecurvature
and nodule formation mark the acute inﬂammatory phase.
This phase is self-limiting, typically lasting between six and
eighteen months. Because the disease is evolving during this
phase,thepatient’spain,thedegreeofcurvature,andthesize
of the plaque may also undergo change. The chronic phase is
characterized by minimal or no pain with stable nodule size
a n dd e g r e eo fp e n i l ed e f o r m i t y[ 8].
4. TREATMENT
A variety of medical (i.e., nonsurgical) treatments with iso-
lated reports of treatment “successes” have been published,
butnonehavebeensubstantiatedinarandomizedcontrolled2 Advances in Urology
Figure 1: Penile deformity secondary to Peyronie’s disease.
fashion [9]. A thorough review of these therapies is beyond
the scope of this article.
Surgical techniques for correcting the penile deformity
from PD all share the same goals: correcting the curvature,
preserving erectile function and penile length, and min-
imizing morbidity. For men with good erectile function,
t w om a i ns u r g i c a lc o n c e p t sh a v eb e e np o p u l a r i z e d :( 1 )
lengthening the concave contracted side using a graft (with
or without plaque incision/excision), and (2) shortening
the convex, noncontracted side using tunical excision or
plication.Formenwithpoorerectilefunctionandcurvature,
placement of a penile prosthesis to correct the erectile
functioncanbesuﬃcientifthedegreeofcurvatureismild. If
thecurvatureismoresevere,acombinationofoneofthetwo
approaches above with prosthesis placement is the preferred
method of surgical repair.
4.1. TheNesbitprocedure
The original tunical shortening procedure—the Nesbit pro-
cedure (named after the surgeon who ﬁrst described it)—
wasinitiallyappliedtothosewithcongenitalpenilecurvature
and later used for PD [10]. The method involved excising
an ellipse of tunica on the side opposite the curvature,
thereby straightening the penis. Though Nesbit’s concepts
have helped to guide the other surgical techniques, the
Nesbit procedure itself is fraught with complications includ-
ing penile shortening, recurrence of curvature, cavernous
tissue herniation, and erectile dysfunction [11]. The Nesbit
procedure is increasingly being replaced by one of the two
surgical techniques described below.
4.2. Penileplication
Initially introduced by Essed and Schroeder as a less-
invasive surgical option for PD, penile plication involves
shortening the convex side of the curvature without excising
the tunica (Figure 2)[ 12]. Lue expanded on this procedure
by describing his “16 dot” technique that is rapid, involves
no dissection of the neurovascular bundles or the urethra,
spares the patient from tunical incision or excision, and
reliablyresultsinastraightpenisintheappropriatelyselected
patient. The procedure may be done with less potential
morbidity to the patient under local anesthesia [13]. The
Figure 2: Correction of Peyronie’s with corporeal plication.
relatively straightforward nature of the procedure, however,
isbalancedbyitslimitedapplicabilitytoPDpatients.Patients
with bottleneck deformities, hourglass deformities, or lateral
indentations are not appropriately treated with plication; in
fact,theprocedureisalmostexclusivelyapplicabletopatients
with simple curvature. It is the authors’ experience, however,
that the majority of patients with PD ﬁt into this category.
Penile plication is associated with a number of well-
described potential drawbacks that should be discussed in
full detail with the patient. First, penile shortening has been
reported from 41 to 90% of the time and is indeed the major
drawback for most PD patients. PD patients with severe
contraction may thus not be ideal candidates for plication;
however, these patients often have an element of erectile
dysfunction and may be better suited for receiving a penile
implant. Second, sexual or erectile dysfunction associated
with plication has been reported anywhere from 7 to 40%
of the time in various studies. Other potential drawbacks
described in previous studies include loss of penile sensation
in3–48%ofpatientsandpermanentpalpableknotsreported
as “bothersome” in 12–18% of patients [13–16].
A study from 2007 reported patient-perceived outcomes
from the plication procedure in 57 patients who had
undergone the penile plication procedure for PD over a 10
year period [17]. With a median follow-up of 51 months,
90% reported a satisfactory cosmetic result, though only
71% reported a satisfactory functional result deﬁned as a
“straight or almost straight penis on erection with pain-free
penetration and normal sexual intercourse.” Interestingly,
the subset analysis of long-term patients pointed to excellent
subjective durability of the plication procedure. 82% of these
patients reported satisfactory cosmesis and 71% reported
functional satisfaction. No objective data is presented, but,
in our opinion, patient-perceived outcomes on the suc-
cess, especially functionally, of the procedure should be of
paramount importance when describing the outcomes of the
procedure.
4.3. Plaqueincision/excisionwithgrafting
Conceptually, plaque incision or excision with venous graft-
ing approaches the contralateral aspect of the curvature—
the concave side—with the aim to lengthen the curvature
onthatcontractedside(Figure 3).BothincisionandexcisionViet Q. Tran et al. 3
Figure 3: With the neurovascular bundles retracted laterally by
the vessel loops, an H-incision is made at the point of maximal
curvature.
of the plaque with grafting have been described with similar
results, but no studies have compared results from the two
procedures. Additionally, the use of both autologous and
syntheticgraftshavebeendescribed,withthesyntheticgrafts
reported as being less elastic with a potential predisposition
toward wound infection [18]. Similar to the intracorporeal
space, venous grafts are lined by vascular endothelium
and are, therefore, theoretically more physiologic than
other autologous tissues. Additionally, venous grafts provide
excellentelasticityanddurability.Weprefertousesaphenous
vein grafting because it is easy to harvest, reliably provides
suﬃcient length and width, and is associated with little
morbidity during harvest [19].
Side eﬀects and complications of vein grafting proce-
dures have also been well described. Initial results from
the procedure have always been promising, with excellent
patient satisfaction (86–92%) and high rates of penile
straightening (59–96%) in the ﬁrst 12 months. A recent
study involving 70 patients treated with plaque incision
with venous grafting with a mean follow-up of 41.7
months reported 53/70 patients (75.7%) with “completely
straightened” penile curvature. Of the remaining patients,
12.8% had residual curvature less than 20 degrees and the
remaining 11.4% had curvature more than 20 degrees [20].
Interestingly, the lack of durability of the results has led to a
more cautious consideration of the applicability of tunical
lengthening procedures in the urological community. Two
studies presenting ﬁve-year follow-up data reported a lack of
durability of the initial promising results with vein grafting.
The ﬁrst study identiﬁed a signiﬁcant decrease in patient
satisfaction due to either erectile dysfunction (22.5%) or
penile shortening (35%) while the second study reported
overall satisfaction falling from 86% initially to 60% at ﬁve
years [21, 22]. One of the reasons cited in the latter study for
adecreaseinsatisfactionwasasubjectivelossofpenilelength
occurring in all of the patients at ﬁve years. Theoretically,
tunical lengthening procedures should actually prevent or
improve the penile shortening often associated with PD,
but many men nonetheless complained of a reduction in
penile length. Objective data from the same institution with
32 months of follow-up reported no change in mean pre-
versuspostoperativepenilelength,despiteapatient-reported
shortening in 40% of this group [23].
Clearly, the objective and patient reported assessment of
penile length is incongruous, which should be considered
when counseling patients on the “tunical lengthening”
procedures. Additionally, the reported long-term results of
the procedure have led to some skepticism in the urologic
community about the durability of the procedure, which
should be conveyed to the patient when describing the long-
term outcomes.
4.4. Penileplicationversusplaqueincisionwithvein
grafting
A recent study from our institution compared subjective
patient reported experiences of tunical plication procedures
(n = 35) with plaque incision and saphenous vein grafting
procedures (n = 32) at one year of follow-up [24]. The
short interval of follow-up is not ideal, especially with the
questionable durability as described above, but nonetheless
the results of our study are compelling. There were no
statistically signiﬁcant diﬀerences between the two groups
with respect to straightening, overall patient satisfaction,
erectile pain, and penile shortening. Patients who underwent
plication were more likely to experience palpable sutures
postoperatively but only 14% of patients reported this to
be of a signiﬁcant concern. Patients who underwent plaque
incision with vein grafting were more likely to experience a
loss in sensation as well as a loss in erectile rigidity. They
were also more likely to be unable to have intercourse. Not
surprisingly, the principle reason for the inability to have
intercourse postoperatively was due to the loss in erectile
rigidity. Loss in sensation was a signiﬁcant patient concern
in about one third of patients when it did occur. Length of
operative times for the two groups varied drastically with an
average time of 71 minutes for the plication group versus an
average time of 234 minutes for the plaque incision and vein
grafting group (P<. 0001).
Based on the results of our study and the literature, at
ourinstitutionwecurrentlyoﬀerbothprocedurestopatients
with simple curvature secondary to PD. The literature has
not clearly shown an advantage of one technique over the
other in terms of long-term functional or cosmetic results.
Indeed, recent literature has even pointed to a relative lack of
functional durability of the vein grafting technique relative
to plication, though this has never been demonstrated in a
clinical trial or with objective data. All of this, as well as a
description of the surgical technique, is described in detail
when counseling patients pre-operatively.
In patients with more complex anatomic abnormalities
due to PD (hourglass deformities, bottleneck deformities,
or lateral indentations), we do not oﬀer plication. These
patients can clearly not be adequately treated with plication
and require more extensive reconstructive and grafting
technique.
5. CONCLUSION
The understanding and management of Peyronie’s disease
has been challenging but is improving. In reviewing the
evolution of the surgical treatments, various reﬁnements4 Advances in Urology
have evolved. This evolution has not led to one ideal
surgical procedure which corrects all cases of PD, but rather
there now exist a repertoire of surgical techniques that can
be oﬀered by urologists and selectively utilized for each
individual’s deformity. The surgical management of PD
should always involve patient counseling of the diﬀerent
operative approaches and additionally should emphasize
how these approaches will best meet patients’ expectations.
Being informed of the advantages and disadvantages of
each surgical technique, patients are better able to make an
informed decision.
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